Medicare Advantage provider incentives can reward care quality, shift responsibility for medical costs to a physician group, or give that group a share of the plan’s risk-adjusted revenue. When a diagnosis raises the plan’s payment, a provider contract can pass part of the increase to the practice. The physician receiving a coding request may see a clinical question. The employer, management company and health plan may also see a financial opportunity.
A Medicare Advantage fraud inquiry follows those relationships through the diagnosis and the money. Who owns the practice, who sets its coding targets and who receives the additional payment can be different organizations. The contract connects them.
Medicare Advantage provider incentives include quality bonuses, capitated payments that put medical costs on the practice, and a share of diagnosis-based revenue. The contract determines which result earns the payment and which organization receives it.
Under capitation, a practice receives a set payment per patient, usually each month, and must cover the agreed services from that payment. More visits do not bring more capitation revenue. The Centers for Medicare & Medicaid Services’ physician incentive rules distinguish that arrangement from payments tied to care quality or patient satisfaction.
The scope of the contract matters as much as its rate. It may cover the physician’s own services, care ordered from other providers, or both professional and institutional care. A group bearing responsibility for more of that spending has a financial interest in the cost of referrals as well as the revenue coming in.
At the plan level, Medicare’s star ratings affect both the payment benchmark and the share of the bid-to-benchmark difference available for extra benefits. A quality score and a diagnosis-based risk score reach the money through different routes.
A risk-score target tied to physician compensation puts the diagnosis itself into the financial calculation. In the clinic, that pressure can arrive as a prompt in the medical record or a request to add a diagnosis after the visit. The American Institutes for Research describes coding prompts and aggressive documentation incentives.
In Kaiser’s case, the government alleged that queries urged physicians to add diagnoses they had not considered or addressed at the visit, and that financial bonuses depended on diagnosis goals.
Payments for bringing members into a plan reward a different result. The government’s MCS Advantage settlement announcement described alleged gift cards to providers’ administrative staff to induce Medicare Advantage enrollments. An office incentive can be aimed at changing where a patient enrolls, as well as what goes into the chart.
Medicare pays the health plan monthly, and eligible diagnoses help set the enrollee’s risk score, which multiplies the plan’s base payment rate. The charge for the visit is only the start of the payment trail from a diagnosis to plan revenue.
The provider’s share comes next. A contract can link the group’s revenue to the payment the plan receives. The American Institutes for Research describes one such arrangement, sub-capitation, in its 2026 report on Medicare Advantage fraud, waste and abuse. The plan pays the group upfront, and the group pays its physicians on a capitated basis. The report explains why both sides care about the score:
This arrangement is typically structured as a percentage of premium, meaning that as coding intensity increases, Medicare’s payment (or premium) to the plan increases, and with it the provider’s revenue also increases.
Medicare Advantage Fraud, Waste, and Abuse Policy Options, American Institutes for Research, 2026
The group may bear medical costs against that revenue. A more expensive patient and a more extensively coded patient affect different sides of its accounts. The financial question is how the agreement defines the payment and the care the group must finance.
Management and data work add another layer. A management company may run coding reviews and audits for a practice while the plan submits the payment data. Its instructions and responsibilities belong alongside the provider agreement when we examine who controlled the work. Independent Health owned DxID, a vendor paid for retrospective chart review. A review fee tied to additional revenue gives the vendor its own interest in the result. The provider’s clinical record, the vendor’s output and the plan’s payment submission each show a different part of the transaction.
The government’s provider cases describe risk-sharing agreements that carried diagnosis revenue beyond the insurer. They put the financial relationship beside the coding conduct the government alleged.
In its Beaver Medical Group settlement announcement, the Justice Department said plans often paid Beaver a share of the Medicare payments for beneficiaries under its care. That gave the group a financial incentive to submit additional diagnosis codes. Beaver and a physician agreed in 2019 to a combined $5,039,180 settlement over allegedly invalid diagnoses reported to the plans. The provider could benefit even though the federal payment went to the insurer first.
Monogram Health agreed to pay $2.4 million in August 2026. The government alleged that it knowingly submitted diagnoses that were clinically inaccurate, unsupported by the medical records, or did not require or affect care, treatment or management. The Justice Department expressly connected its risk-sharing agreements to the incentive to increase patients’ scores and the corresponding Medicare payments.
The DaVita settlement announced in 2018 reached $270 million. It covered practices at HealthCare Partners, the physician association DaVita had acquired in 2012. The government alleged that improper guidance directed physicians to use a higher-paying code for a spinal condition, with DaVita and HealthCare Partners sharing in the inflated payments the plans received.
That settlement also resolved a whistleblower’s allegations of chart reviews that added diagnoses while ignoring codes that should have been deleted. The acquisition, the coding instructions and the failure to correct tell different parts of the story. The alleged conduct explains why the money was challenged.
Across these cases, the contract helps explain why the provider wanted a higher score. The medical records and coding decisions explain the government’s allegations about how it got one.
Plan-owned practices put the insurer and a recipient of its medical payments inside the same corporate group. Ownership can also give that group greater control over the records, coding systems and referrals that influence its revenue.
Company filings make those relationships concrete. CVS Health’s acquisition disclosures identify its purchases of Oak Street Health and Signify Health in 2023. Humana’s annual filing describes CenterWell’s primary-care clinics and reports that most of CenterWell’s revenue in 2025 came from transactions with other Humana segments. Those internal payments matter when examining where the corporate group earns its money.
National size and local influence can look very different. The changing landscape of primary care: an analysis of payer-primary care integration, published in Health Affairs Scholar in 2025, put payer-operated practices at 4.2% of national primary-care service volume in 2023.
The same study of payer-operated practices found that Optum held over 35% of the primary-care market in three large counties. A national average can leave a physician’s local market almost invisible.
The Medicare Payment Advisory Commission cites a working paper associating substantial increases in risk scores with primary-care practices joining integrated companies or being acquired by them, for some insurer-provider combinations. The timing gives an insider a concrete question: what changed in the coding process when management changed?
The American Institutes for Research describes how integration can improve coordination and data sharing. It also identifies greater control over charts and the ability to steer patients toward affiliated providers. Those are operating decisions an insider can recognize in the healthcare business, alongside the ownership shown in a filing.
The Medicare Advantage medical loss ratio sets a minimum share of revenue for patient care and quality improvement. It does not show all the profit a corporate parent may retain through its provider businesses.
The Medicare Advantage medical loss ratio requirement sets the floor at 85%. Because the limit is a proportion, higher revenue increases the dollars available within the remaining 15% for administration and profit. Raising risk-adjusted revenue therefore benefits a plan even while it meets the ratio.
Ownership adds a second question. A payment recorded as medical spending by the insurance business becomes revenue for the provider business. If the parent owns both, some of the money can remain inside the group as provider profit. The American Institutes for Research describes the risk that a plan pays its own providers more than it pays outside providers, increasing reported medical spending without delivering more care.
The payment can change accounting categories without leaving the corporate family. For an insider in finance, the consequential records are the internal prices, the services those prices buy and the amount retained by the provider. A plan-level percentage cannot answer those questions.
In its March 2026 Medicare Advantage status report, the Medicare Payment Advisory Commission said plans reported 13% of their bids for administration and profit. It also warned that plans may understate those amounts by reclassifying profits retained through payments to plan-owned providers. The bid’s reported allowance and the parent company’s economic benefit can be different amounts.
MedPAC’s findings on efficiency make the point sharper. Its projections were consistent with plans reducing medical expenses by 18% below what the same enrollees would have cost in fee-for-service Medicare. They were also consistent with higher payments from selection and coding. Lower care costs and higher government payments can coexist. Taxpayers can pay more even when the plan spends less on care.
For a risk-sharing practice, that distinction reaches its own accounts. Managing care costs changes spending. Adding payment-relevant diagnoses changes revenue. Paying an affiliated provider changes where the money appears. Calling all of that alignment leaves the financial explanation unfinished.
MedPAC says public data do not systematically account for ownership relationships between plans and health care providers. Someone inside the business may understand the management arrangement, the pricing decision or the route a coding instruction took in a way a public ownership list cannot show. That is why the contract and the operating records belong beside the reported ratio.
The government alleged that Anthem knew its provider contracts encouraged over-reporting and failed to compare submitted diagnoses with chart-review findings that could expose unsupported codes.
Its complaint described the incentive directly:
Anthem understood that its “capitated” or “profit-sharing” relationships with providers created a strong financial incentive for those providers to over-report diagnosis codes both in terms of the number and the severity of reported medical conditions for Part C beneficiaries.
United States v. Anthem, Inc., government complaint, paragraph 78
The complaint alleged that Anthem’s internal assessment classified unsupported diagnosis submissions as a high risk. Its programmers could build the comparison, but the company did not run it. The government was describing knowledge and a decision about what to check.
Delegating the work still leaves a documented chain of responsibilities. CMS’s plan-contract rules require contracts to identify delegated activities and reporting responsibilities. The plan remains responsible for its Medicare contract, and contractors that generate payment data must also vouch for it.
A coding request, a revenue projection and an internal finding followed by an uncorrected submission can connect what different departments knew.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know how your practice’s coding requests connect to its risk-sharing payments or management decisions, speak with our whistleblower experts about that connection. We work beside you to build your strongest Medicare Advantage whistleblower case around the medical evidence, the financial arrangements and the decisions that preserved unsupported revenue. We bring in Medicare Advantage whistleblower lawyers who understand provider contracts and risk adjustment, and remain your partners throughout the case.